Planning Capital Management Corporation’s Dare Bioscience DARE Stock Holding History

Planning Capital Management Corporation’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$30	Buy	+9	New	+$31	﹤0.01%	757

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Planning Capital Management Corporation's DARE Position: Q3 2024 in Review

Planning Capital Management Corporation opened a new position in Dare Bioscience (DARE) in Q3 2024: 9 shares worth $30. The stake represents ﹤0.01% of the portfolio and ranks #757 among its holdings.

22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Planning Capital Management Corporation held 9 shares of Dare Bioscience worth $30 as of Q3 2024.
Dare Bioscience was a new Planning Capital Management Corporation position in Q3 2024.
Dare Bioscience made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #757 holding.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.